The role of nitric oxide in the central control of blood pressure

Biochem Biophys Res Commun. 1995 Jan 5;206(1):77-81. doi: 10.1006/bbrc.1995.1011.

Abstract

In these studies blood pressure responses to intracerebroventricular (i.c.v.) infusions were recorded in anesthetized rats. NO donors caused a fall in blood pressure, whereas L-NAME, which blocks the enzyme (NOS) that produces NO, caused a rise in blood pressure. Calcium, i.c.v., stimulates NOS to lower blood pressure. The depressor action of NO is reduced by blocking the action of cGMP. This central NO/cGMP system is tonically active to maintain blood pressure at a normal level.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Oxidoreductases / antagonists & inhibitors
  • Animals
  • Arginine / administration & dosage
  • Arginine / analogs & derivatives*
  • Arginine / pharmacology
  • Blood Pressure / drug effects*
  • Calcium Chloride / administration & dosage
  • Calcium Chloride / pharmacology*
  • Cerebral Ventricles / drug effects
  • Cerebral Ventricles / physiology*
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / pharmacology
  • Cyclic GMP / physiology
  • Dose-Response Relationship, Drug
  • Injections, Intraventricular
  • Male
  • NG-Nitroarginine Methyl Ester
  • Nitric Oxide / physiology*
  • Nitric Oxide Synthase
  • Rats
  • Rats, Inbred WKY
  • Thionucleotides / pharmacology

Substances

  • Thionucleotides
  • 8-bromoguanosino-3',5'-cyclic monophosphorothioate
  • Nitric Oxide
  • Arginine
  • Nitric Oxide Synthase
  • Amino Acid Oxidoreductases
  • Cyclic GMP
  • Calcium Chloride
  • NG-Nitroarginine Methyl Ester